Jefferies Says Sell Merck, Buy Bristol-Myers Heading Into New Year

Shares of Merck are sliding after Jefferies analyst Jeffrey Holford downgraded the stock to Underperform.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.